March 01, 2022
A group of Acthar gel tort claimants asked a Delaware bankruptcy judge on Tuesday to reject a request by Mallinckrodt to continue an order pausing Acthar suits, saying there is no longer a "legal or practical" reason to hold up their claims against a third party.
February 14, 2022
Mallinckrodt PLC is asking a Delaware bankruptcy judge for one final extension of an order pausing lawsuits against the drugmaker relating to its marketing of Acthar gel products, saying it needs the injunction to see it through to the end of its Chapter 11 case.
February 04, 2022
A Delaware federal bankruptcy court on Thursday confirmed Mallinckrodt PLC's Chapter 11 plan, which the drugmaker said reduces the company's total debt by approximately $1.3 billion.
January 25, 2022
Drugmaker Mallinckrodt PLC is asking a Delaware bankruptcy judge to approve a $13.9 million settlement with a subsidiary of German pharmaceutical company Fresenius Kabi to end a dispute over supply payments Mallinckrodt cut off when it entered Chapter 11.
January 06, 2022
Mallinckrodt PLC Thursday made its final arguments for its Chapter 11 plan to a Delaware bankruptcy judge, with the drugmaker defending the plan against assertions that it's unfair to holders of claims connected to its Acthar gel and contains improper liability releases.
January 04, 2022
Holders of claims connected to Mallinckrodt PLC's Acthar gel made their final arguments to a Delaware bankruptcy judge on Tuesday that they will receive an unfairly small cash share from the unsecured creditor settlement in the drugmaker's proposed Chapter 11 plan.
December 17, 2021
Mallinckrodt objected to a request by Acthar antitrust claimants to withdraw their Chapter 11 claims, telling a Delaware bankruptcy judge Friday that it needs a ruling on the claims to secure a post-bankruptcy distribution deal.
December 13, 2021
Witnesses for supporters of Mallinckrodt's proposed Chapter 11 plan Monday told a Delaware bankruptcy judge that the plan's proposed $1.75 billion opioid claims deal is reasonable and the distribution of its unsecured creditors' settlement is fair.
December 10, 2021
A restructuring adviser for Mallinckrodt told a Delaware bankruptcy judge Friday that the drugmaker's proposed Chapter 11 plan would be impossible without the company's settlements of opioid injury and federal Acthar reimbursement claims.
December 07, 2021
Mallinckrodt's top restructuring executive defended the fairness of the drugmaker's proposed Chapter 11 plan on Tuesday, as he faced questions about whether it would shortchange holders of antitrust claims over the sales of its Acthar gel.